Biological Information

Background Information:

11β-hydroxysteroid dehydrogenase 1 (11β-HSD1) belongs to the family of oxidoreductases, also known as cortisone reductase, is an NADPH-dependent enzyme that catalyzes conversion of cortisone to cortisol, highly expressed in metabolic tissues including liver, adipose tissue. Over-expression of 11β-HSD1 has been associated with obesity, insulin resistance. 11β-HSD1 inhibition may be useful for treatment of obesity and metabolic syndrome.

Family:

Oxidoreductase

Sub Family:

Oxidase

Class:

Lipid metabolism

Protein Name:

11-beta-HSD1

Uniprot Number:

X5D2L1

Protein Aliases:

11-beta-Hydroxysteroid Dehydrogenase 1

Gene Name:

HSD11B1HSD11B1

Gene ID:

3290

Gene Aliases:

SDR26C1

Accession Number:

NM_181755

Organism:

Human

Construct Details:

Full length, Recombinant

Assay Information

Assay Type:

Biochemical

Assay Sub Type:

Enzymatic

Functional Mode:

Antagonist

Detection Method:

Spectrofluorimetry

Platform:

Spectrofluorimetry

Measured Response:

Fluorescence

Testing Information

Procedure Summary:

Human recombinant 11-beta-HSD 1 enzyme expressed in HEK293T cells is used. Test compound and/or vehicle is preincubated with 8 µg/ml active enzymeǂ in modified Phosphate buffer pH 7.6 for 15 minutes at 37°C. The reaction is initiated by addition of 1 µM cortisone substrate for another 30 minute incubation period. Determination of the amount of cortisol formed is detected spectrofluorimetrically by Cortisol HTRF kit. Compounds are screened at 10 µM.

Substrate:

1 µM Cortisone

Incubation:

30 min at 37°C

Control Inhibitor:

PF 915275

Criteria For Significance:

≥ 50% of max stimulation or inhibition

Test Concentration / Dose:

Suggested concentration for initial testing is 10 uMSuggested concentration for initial testing is 10 uM

Minimum Order Quantity:

2

Turnaround Time

Standard:

15 Business Days

Reference Compound Data

PubChem ID

6918651

Name

BVT2733

Measurement

39μM - IC50

PubChem ID

23725123

Name

PF 915275

Measurement

0.041μM - IC50

Clinical Relevance

Therapeutic Area:

Metabolic Diseases

Additional Information

Brand:

LeadHunter

Testing Location:

Taiwan - Taipei